| 書目名稱 | Clinical Use of Antiviral Drugs | | 編輯 | Erik Clercq | | 視頻video | http://file.papertrans.cn/229/228283/228283.mp4 | | 叢書名稱 | Developments in Medical Virology | | 圖書封面 |  | | 描述 | Antiviral chemotherapy has come of age, and, after an initial slow pro- gress, the development of new antiviral agents has proceeded at a more rapid pace and the perspectives for their clinical use have increased considerably. Now, 25 years after the first antiviral assay (idoxuridine) was introduced in the clinic, it is fitting to commemorate the beginning of the antivirals‘ era. In its introductory chapter B.E. Juel-Jensen touches on what may be con- sidered as five of the most fundamental requirements of an antiviral drug : efficacy, relative non-toxicity, easy solubility, ready availability and rea- sonable cost. Surely, the antiviral drugs that have so far been used in the clinic could still be improved upon as one or more of these five essential demands are concerned. How is all began is narrated by W.H. Prusoff. The first antiviral drugs to be used in humans were methisazone and idoxuridine, the former, which is now of archival interest, in the prevention of smallpox, the latter, which was approved for clinical use in the United States in 1962, for the topical treatment of herpetic keratitis. In terms of potency, also because of solubility reasons, idoxuridine has been super | | 出版日期 | Book 1988 | | 關(guān)鍵詞 | AIDS; infection; virus | | 版次 | 1 | | doi | https://doi.org/10.1007/978-1-4613-1715-9 | | isbn_softcover | 978-1-4612-8966-1 | | isbn_ebook | 978-1-4613-1715-9 | | copyright | Martinus Nijhoff Publishing, Boston 1988 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-19 22:53
發(fā)表于 2025-3-21 19:38:19
